In vitro growth responses of bifidobacteria and enteropathogens to bovine and human lactoferrin

Digestive Diseases and Sciences

Volumn 48, Issue 7, 2003, Pages 1324-1332

  Griffiths, Elizabeth A ^a,b   Duffy, Linda C ^a,b,e   Schanbacher, Floyd L ^c   Dryja, Diane ^a,b   Leavens, Allen ^a,b   Neiswander, Ronald L ^c   Qiao, Haiping ^a,b   DiRienzo, Douglas ^d   Ogra, Pearay ^a,b  

^a CHILDREN S HOSPITAL OF BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d National Dairy Council   (United States)

^e UNIVERSITY AT BUFFALO   (United States)

Author keywords

Bifidobacteria; E. coli O157:H7; Lactobacillus; Lactoferrin; Probiotic

Indexed keywords

LACTOFERRIN; PROBIOTIC AGENT;

ARTICLE; BACTERIAL GROWTH; BACTERIAL OVERGROWTH; BACTERIUM CULTURE; BIFIDOBACTERIUM; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM LONGUM INFANTIS; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; IN VITRO STUDY; INTESTINE FLORA; LACTOBACILLUS ACIDOPHILUS; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM;

ANIMALS; BIFIDOBACTERIUM; CATTLE; ESCHERICHIA COLI; HUMANS; IRON COMPOUNDS; LACTOBACILLUS ACIDOPHILUS; LACTOFERRIN; SALMONELLA TYPHIMURIUM;

EID: 0038726407     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024111310345     Document Type: Article

References (51)

1. Yoshioka H, Iseki K, Fujita K: Development and differences of intestinal flora in the neonatal period in breast-fed and bottle-fed infants. Pediatrics 72:317-321, 1983
2. Stark PL, Lee A: The microbial ecology of the large bowel of breast-fed and formula-fed infants during the first year of life. J Med Microbiol 15:189-203, 1982
3. Benno Y, Sawada K, Mitsuoka T: The intestinal microflora of infants: composition of fecal flora in breast-fed and bottle-fed infants. Microbiol Immunol 28:975-986, 1984
4. Deitch EA: Role of bacterial translocation in necrotizing entercolitis. Acta Paediatr 396(suppl):33-36, 1994
5. Berg RD: Bacterial translocation from the gastrointestinal tract. Adv Exp Med Biol 473:11-30, 1999
6. Roberts AK, Chierici R, Sawatzki G, Hill MJ, Volpato S, Vigi V: Supplementation of an adapted formula with bovine lactoferrin: 1. Effect on the infant faecal flora. Acta Paediatr 81:119-124, 1992
7. Kunz C, Rudloff S: Biological functions of oligosaccharides in human milk. Acta Paediatr 82:903-912, 1993
8. Teraguchi S, Shin K, Fukuwatari Y, Shimamura S: Glycans of bovine lactoferrin function as receptors for the type 1 fimbrial lectin of Escherichia coli. Infect Immun: 64:1075-1077, 1996
9. Newburg DS: Oligosaccharides in human milk and bacterial colonization. J Pediatr Gastroenterol Nutr 30:S8-S17, 2000
10. Dai D, Walker WA: Protective nutrients and bacterial colonization in the immature human gut. Adv Pediatr 46:353-382, 1999
11. Duffy LC, Riepenhoff-Talty M, Byers TE, LaScolea LJ, Zielezny MA, Dryja DM, Ogra PL: Modulation of rotavirus enteritis during breast-feeding. Implications on alterations in the intestinal bacterial flora. Am J Dis Child 140:1164-1168, 1986
12. Duffy LC, Zielezny MA, Riepenhoff-Talty M, Dryja D, Sayahtaheri-Altaie S, Griffiths E, Ruffin D, Barrett H, Ogra PL: Reduction of virus shedding by B. bifidum in experimentally induced MRV infection. Dig Dis Sci 39:2334-2340, 1994
13. Saavedra JM, Bauman NA, Oung I, Perman JA, Yolken RH: Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 344:1046-1049, 1994
14. Caplan MS, Jilling T: Neonatal necrotizing enterocolitis: possible role of probiotic supplementation. J Pediatr Gastroenterol Nutr 30:S18-S22, 2000
15. Qiao H, Duffy LC, Griffiths EA, Dryja D, Leavens A, Rossman J, Rich G, Riepenhoff-Talty M, Locniskar M: Immune responses in rhesus rotavirus-challenged Balb/c mice treated with bifidobacteria and prebiotic supplements. Pediatr Res 51:750-755, 2002
16. Langhendries JP, Detry J, Van Hees J, Lamboray JM, Darimont J, Mozin MJ, Secretin MC, Senterre J: Effect of a fermented infant formula containing viable bifidobacteria on the fecal flora composition and pH of healthy full-term infants. J Pediatr Gastroenterol Nutr 21:177-181, 1995
17. Kitajima H, Sumida Y, Tanaka R, Yuki N, Takayama H, Fujimura M: Early administration of Bifidobacterium brave to preterm infants: randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 76:F101-F107, 1997
18. Walker WA, Duffy LC: Diet and bacterial colonization: role of probiotics and prebiotics. J Nutr Biochem 9:668-675, 1998
19. Bernet MF, Brassart D, Neeser JR, Servin AL: Adhesion of human bifidobacterial strains to cultured human intestinal epithelial cells and inhibition of enteropathogen-cell interactions. Appl Environ Microbiol 59:4121-4128, 1993
20. Lonnerdal B, Iyer S: Lactoferrin: molecular structure and biological function. Annu Rev Nutr 15:93-110, 1995
21. Nuijens JH, van Berkel PH, Schanbacher FL: Structure and biological actions of lactoferrin. J Mammary Gland Biol Neoplasia 1:285-295, 1996
22. Sanchez L, Calvo M, Brock JH: Biological role of lactoferrin. Arch Dis Child 67:657-661, 1992
23. Chierici R, Vigi V: Lactoferrin in infant formulae. Acta Paediatr(suppl) 402:83-88, 1994
24. Bullen JJ: Iron-binding proteins in milk and resistance to Escherichia coli infection in infants. Postgrad Med J 51:67-70, 1975
25. Brock JH: Lactoferrin in human milk: its role in iron absorption and protection against enteric infection in newborn infants. Arch Dis Child 55:417-421, 1980
26. Arnold RR, Russell JE, Champion WJ, Brewer M, Gauthier JJ: Bactericidal activity of human lactoferrin: differentiation from the stasis of iron deprivation. Infect Immun 35:792-799, 1982
27. Ellison RT III, Giehl TJ, LaForce FM: Damage of the outer membrane of enteric gram-negative bacteria by lactoferrin and transferrin. Infect Immun 56:2774-2781, 1988
28. Appelmelk BJ, An YQ, Geerts M, Thijs BG, deBoer HA, MacLaren DM, deGraaff J, Nuijens JH: Lactoferrin is a lipid A-binding protein. Infect Immun 62:2628-2632, 1994
29. Petschow BW, Talbott RD: Response of Bifidobacterium species to growth promoters in human and cow milk. Pediatr Res 29:208-213, 1991
30. Hentges DJ, Marsh WW, Petschow BW, Thal WR, Carter MK: Influence of infant diets on the ecology of the intestinal tract of human flora-associated mice. J Pediatr Gastroenterol Nutr 14:146-152, 1992
31. Bishop JG, Schanbacher FL, Ferguson LC, Smith KL: In vitro growth inhibition of mastitis-causing coliform bacteria by bovine apo-lactoferrin and reversal of inhibition by citrate and high concentrations of apo-lactoferrin. Infect Immun 14:911-918, 1976
32. Mazurier J, Spik G: Comparative study of the iron-binding properties of human transferrins. I. Complete and sequential iron saturation and desaturation of the lactotransferrrin. Biochim Biophys Acta 629:399-408, 1980
33. Schanbacher FL, Pattanajitvilai S, Neville MC: Post-transcriptional regulation of bovine and human lactoferrin: species differences and influence of mRNA regions. In Lactoferrin: interactions and biological functions. Proceedings 2nd International Conference on Lactoferrin. TW Hutchins, B Lonnerdal (eds). Totowa, New Jersey, Human Press, 1997, pp 81-95
34. Schanbacher FL, Talhouk RS, Murray FA: Biology and origin of bioactive peptides in milk. Livest Prod Sci 50:105-123, 1997
35. Castellino FJ, Fish WW, Mann KG: Structural studies on bovine lactoferrin. J Biol Chem 245:4269-4275, 1970
36. van Berkel PH, Geerts ME, van Veen HA, Kooiman PM, Pieper FR, de Boer HA, Nuijens JH: Glycosylated and unglycosylated human lactoferrins both bind iron and show identical affinities towards human lysozyme and bacterial lipopolysaccharide, but differ in their susceptibilities towards tryptic proteolysis. Biochem J 312:107-114, 1995
37. Clarke GM: Statistics and Experimental Design. New York, John Wiley & Sons, 1994
38. Godfrey K: Comparing the means of several groups. In Medical Uses of Statistics. JC Bailar, F Mosteller (eds). Waltham, Massachusetts, NEJM Books, 1986, pp 205-234
39. Petschow BW, Talbott RD, Batema RP: Ability of lactoferrin to promote the growth of Bifidobacterium spp. in vitro is independent of receptor binding capacity and iron saturation level. J Med Microbiol 48:541-549, 1999
40. Ellison RT III, Giehl TJ: Killing of gram-negative bacteria by lactoferrin and lysozyme. J Clin Invest 88:1080-1091, 1991
41. Bellamy W, Takase M, Wakabayashi H, Kawase K, Tomita M: Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. J Appl Bacteriol 73:472-479, 1992
42. Yamauchi K, Tomita M, Giehl TJ, Ellison III RT: Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment. Infect Immun 61:719-728, 1993
43. Erdei J, Forsgren A, Naidu AS: Lactoferrin binds to porins OmpF and OmpC in Escherichia coli. Infect Immun 62:1236-1240, 1994
44. Wharton BA, Balmer SE, Scott PH: Faecal flora in the newborn. Effect of lactoferrin and related nutrients. Adv Exp Med Biol 357:91-98, 1994
45. Wharton BA, Balmer SE, Scott PH: Sorrento studies of diet and fecal flora in the newborn. Acta Paediatr Jpn 36:579-584, 1994
46. Prentice A, MacCarthy A, Stirling DM, Vasquez-Velasquez L, Ceesay SM: Breast-milk IgA and lactoferrin survival in the gastrointestinal tract - a study in rural Gambian children. Acta Paediatr Scand 78:505-512, 1989
47. Goldman AS, Garza C, Schanler RJ, Goldblum RM: Molecular forms of lactoferrin in stool and urine from infants fed human milk. Pediatr Res 27:252-255, 1990
48. Britton JR, Koldovsky O: Gastric luminal digestion of lactoferrin and transferrin by preterm infants. Early Human Dev 19:127-135, 1989
49. Salminen S, Isolauri E, Salminen E: Clinical uses of probiotics for stabilizing the gut mucosal barrier: successful strains and future challenges. Antonie van Leeuwenhoek 70:347-358, 1996
50. Glynn MK, Bopp C, Dewitt W, Dabney P, Mokhtar M, Angulo FJ: Emergence of multidrug-resistant Samonella enterica serotype typhimurium DT104 infections in the United States. N Engl J Med 338:1333-1338, 1998
51. Reid G: The scientific basis for probiotic strains of Lactobacillus. Appl Environ Microbiol 65:3763-3766, 1999